BTLA Recombinant Protein Cat. No.: 96-832

Availability: In stock

$0.00

 Price Options

$0.00
psi-iconSpecifications
SPECIES:Human
SOURCE SPECIES:HEK293 cells
SEQUENCE:Lys 31 - Ser 150
FUSION TAG:His Tag
TESTED APPLICATIONS:ELISA, WB
APPLICATIONS:This recombinant protein can be used for E, WB. For research use only.
BIOLOGICAL ACTIVITY: Measured by its binding ability in a functional ELISA. Immobilized Human BTLA, His Tag at 5 ug/mL (100 uL/well) can bind Human HVEM, Fc Tag with a linear range of 0.08-10 ug/mL (QC tested).
psi-iconProperties
PURITY:>95% as determined by SDS-PAGE.

Endotoxin level is less than 1.0 EU per ug by the LAL method.
PREDICTED MOLECULAR WEIGHT:15.6 kDa
PHYSICAL STATE:Lyophilized
BUFFER:PBS, pH7.4
STORAGE CONDITIONS:Lyophilized Protein should be stored at -20˚C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚C or -70˚C. Avoid repeated freeze-thaw cycles.
psi-iconAdditional Info
ALTERNATE NAMES:BTLA,CD272
ACCESSION NO.:AAP44003
OFFICIAL SYMBOL:BTLA
GENE ID:151888
psi-iconBackground and References
BACKGROUND:B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
REFERENCES:1) Watanabe N., et al., 2003, Nat. Immunol. 4:670-679.
2) Gavrieli M., et al., 2003, Biochem. Biophys. Res. Commun. 312:1236-1243.
3) Sedy J.R., et al., 2005, Nat. Immunol. 6:90-98.

FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.